Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic, Cleveland, Ohio.
Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic, Cleveland, Ohio.
Surg Obes Relat Dis. 2021 Jan;17(1):208-214. doi: 10.1016/j.soard.2020.10.026. Epub 2020 Nov 23.
Obesity is a risk factor for poor clinical outcomes in patients with coronavirus disease 2019 (COVID-19).
To investigate the relationship between prior metabolic surgery and the severity of COVID-19 in patients with severe obesity.
Cleveland Clinic Health System in the United States.
Among 4365 patients who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between March 8, 2020 and July 22, 2020 in the Cleveland Clinic Health System, 33 patients were identified who had a prior history of metabolic surgery. The surgical patients were propensity matched 1:10 to nonsurgical patients to assemble a cohort of control patients (n = 330) with a body mass index (BMI) ≥ 40 kg/m at the time of SARS-CoV-2 testing. The primary endpoint was the rate of hospital admission. The exploratory endpoints included admission to the intensive care unit (ICU), need for mechanical ventilation and dialysis during index hospitalization, and mortality. After propensity score matching, outcomes were compared in univariate and multivariate regression models.
The average BMI of the surgical group was 49.1 ± 8.8 kg/m before metabolic surgery and was down to 37.2 ± 7.1 at the time of SARS-CoV-2 testing, compared with the control group's BMI of 46.7 ± 6.4 kg/m. In the univariate analysis, 6 (18.2%) patients in the metabolic surgery group and 139 (42.1%) patients in the control group were admitted to the hospital (P = .013). In the multivariate analysis, a prior history of metabolic surgery was associated with a lower hospital admission rate compared with control patients with obesity (odds ratio, 0.31; 95% confidence interval, 0.11-0.88; P = .028). While none of the 4 exploratory outcomes occurred in the metabolic surgery group, 43 (13.0%) patients in the control group required ICU admission (P = .021), 22 (6.7%) required mechanical ventilation, 5 (1.5%) required dialysis, and 8 (2.4%) patients died.
Prior metabolic surgery with subsequent weight loss and improvement of metabolic abnormalities was associated with lower rates of hospital and ICU admission in patients with obesity who became infected with SARS-CoV-2. Confirmation of these findings will require larger studies.
肥胖是 2019 年冠状病毒病(COVID-19)患者临床结局不佳的一个危险因素。
研究严重肥胖患者既往代谢手术后与 COVID-19 严重程度的关系。
美国克利夫兰诊所医疗系统。
在克利夫兰诊所医疗系统 2020 年 3 月 8 日至 2020 年 7 月 22 日期间检测出严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)呈阳性的 4365 例患者中,有 33 例患者有代谢手术史。对这些手术患者进行倾向评分 1:10 匹配,以纳入在 SARS-CoV-2 检测时 BMI≥40kg/m²的非手术患者作为对照组(n=330)。主要终点为住院率。探索性终点包括入住 ICU、住院期间需要机械通气和透析以及死亡率。在倾向评分匹配后,使用单变量和多变量回归模型比较结果。
手术组的平均 BMI 在代谢手术前为 49.1±8.8kg/m²,在 SARS-CoV-2 检测时降至 37.2±7.1kg/m²,而对照组的 BMI 为 46.7±6.4kg/m²。在单变量分析中,手术组有 6(18.2%)例患者和对照组有 139(42.1%)例患者住院(P=0.013)。在多变量分析中,与肥胖对照组患者相比,既往代谢手术史与较低的住院率相关(比值比,0.31;95%置信区间,0.11-0.88;P=0.028)。虽然手术组没有出现 4 项探索性结局,但对照组中有 43(13.0%)例患者需要入住 ICU(P=0.021),22(6.7%)例需要机械通气,5(1.5%)例需要透析,8(2.4%)例患者死亡。
既往代谢手术可减轻体重和改善代谢异常,与肥胖患者感染 SARS-CoV-2 后住院和入住 ICU 率降低有关。需要更大规模的研究来证实这些发现。